Jane E Willoughby

3PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 04, 2024
Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations.

Jane E Willoughby, Lang Dou, Sabyasachi Bhattacharya

|Jan 12, 2022
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.

Julia Moreno-Vicente, Jane E Willoughby, Martin C Taylor

|Jan 11, 2021
Domain binding and isotype dictate the activity of anti-human OX40 antibodies.

Jordana Griffiths, Khiyam Hussain, Hannah L Smith

Pageof 1